Accurate, balanced evidence-based information about medicines

• About us
• CMI search
• News & media
• All publications
• All events
• Careers
• Links
• Contact us

• Home
• Consumers
• Health Professionals
• Members & Stakeholders
• Research & Evaluation

Lumiracoxib (Prexige) for osteoarthiritis Medicine Update April 2007: Lumiracoxib (Prexige) for osteoarthiritis

Description: Since this issue of Medicine Update was published, lumiracoxib (Prexige) has been urgently withdrawn by the Therapeutic Goods Administration.

This document is a PDF file. To view PDF documents you will need to download Adobe Reader from the Adobe website.

Please don't show me this PDF gateway page again for this browser session (this will reset when the browser is closed).